Parabolic Drugs informs about updates

22 Dec 2017 Evaluate

Parabolic Drugs has informed that with reference to e-mail dated 21-12-2017, in regard to deficiency observed in the financial result for the Quarter/Half year ended on 30th September, 2017 with respect to the point, Reconciliation of Profit and Loss not submitted.

The above information is a part of company’s filings submitted to BSE

Parabolic Drugs Share Price

1.05 0.00 (0.00%)
25-Jan-2021 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1781.50
Dr. Reddys Lab 1199.85
Cipla 1468.45
Lupin 2047.95
Zydus Lifesciences 946.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.